Results 201 to 210 of about 70,562 (248)

Exploring the Potential of Calebin‐A in Targeting Obesity‐Related Genes and Pathways

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT Obesity is a global health crisis affecting millions, associated with metabolic disorders such as type 2 diabetes and cardiovascular disease. Calebin‐A, a bioactive compound derived from Curcuma species, has shown promise in managing obesity and its complications.
Ali Mahmoudi   +4 more
wiley   +1 more source

Interpretable machine learning models based on CMR radiomics for predicting left ventricular diastolic dysfunction in patients with metabolic‐associated steatotic liver disease and type 2 diabetes mellitus

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 6, Page 1010-1023, June 2026.
We developed an interpretable machine learning (ML) model combining cardiac magnetic resonance (CMR) radiomics and clinical data to assess left ventricular diastolic dysfunction (LVDD) risk in metabolic‐associated steatotic liver disease (MASLD)/type 2 diabetes mellitus (T2DM) patients, enabling proactive treatment.
Jinying Xia   +8 more
wiley   +1 more source

Maternal opioids downregulate adiponectin receptor signaling and alter growth in offspring: pilot study. [PDF]

open access: yesFront Pediatr
Yen E   +12 more
europepmc   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy